METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis
NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock - Currency: USD
Taking everything into account, MTD scores 5 out of 10 in our fundamental rating. MTD was compared to 55 industry peers in the Life Sciences Tools & Services industry. MTD has an excellent profitability rating, but there are some minor concerns on its financial health. MTD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year MTD was profitable.
In the past year MTD had a positive cash flow from operations.
MTD had positive earnings in each of the past 5 years.
In the past 5 years MTD always reported a positive cash flow from operatings.
1.2 Ratios
MTD's Return On Assets of 26.25% is amongst the best of the industry. MTD outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 43.51%, MTD belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MTD is significantly above the industry average of 13.60%.
The 3 year average ROIC (41.86%) for MTD is below the current ROIC(43.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROIC | 43.51% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
1.3 Margins
Looking at the Profit Margin, with a value of 22.17%, MTD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of MTD has grown nicely.
MTD has a Operating Margin of 28.85%. This is amongst the best in the industry. MTD outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of MTD has grown nicely.
Looking at the Gross Margin, with a value of 60.14%, MTD is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% |
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MTD has less shares outstanding
Compared to 5 years ago, MTD has less shares outstanding
The debt/assets ratio for MTD is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 10.33 indicates that MTD is not in any danger for bankruptcy at the moment.
MTD's Altman-Z score of 10.33 is amongst the best of the industry. MTD outperforms 94.55% of its industry peers.
MTD has a debt to FCF ratio of 2.39. This is a good value and a sign of high solvency as MTD would need 2.39 years to pay back of all of its debts.
MTD has a Debt to FCF ratio of 2.39. This is amongst the best in the industry. MTD outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Altman-Z | 10.33 |
ROIC/WACC4.38
WACC9.93%
2.3 Liquidity
A Current Ratio of 1.01 indicates that MTD should not have too much problems paying its short term obligations.
MTD has a Current ratio of 1.01. This is amonst the worse of the industry: MTD underperforms 83.64% of its industry peers.
A Quick Ratio of 0.70 indicates that MTD may have some problems paying its short term obligations.
The Quick ratio of MTD (0.70) is worse than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.69% over the past year.
The Earnings Per Share has been growing by 12.53% on average over the past years. This is quite good.
The Revenue has been growing slightly by 1.18% in the past year.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.18% on average per year.
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
3.2 Future
The Earnings Per Share is expected to grow by 9.32% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.81% on average over the next years.
EPS Next Y1.85%
EPS Next 2Y6.16%
EPS Next 3Y8.2%
EPS Next 5Y9.32%
Revenue Next Year2.19%
Revenue Next 2Y3.4%
Revenue Next 3Y3.95%
Revenue Next 5Y3.81%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.03, the valuation of MTD can be described as expensive.
Based on the Price/Earnings ratio, MTD is valued a bit cheaper than 67.27% of the companies in the same industry.
MTD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.15.
The Price/Forward Earnings ratio is 25.32, which means the current valuation is very expensive for MTD.
MTD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 67.27% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MTD to the average of the S&P500 Index (21.60), we can say MTD is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.03 | ||
| Fwd PE | 25.32 |
4.2 Price Multiples
MTD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MTD is cheaper than 69.09% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MTD is valued a bit cheaper than the industry average as 74.55% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.09 | ||
| EV/EBITDA | 21.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)15.67
PEG (5Y)2.32
EPS Next 2Y6.16%
EPS Next 3Y8.2%
5. Dividend
5.1 Amount
No dividends for MTD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1174.72
-9.82 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.55%
Inst Owner Change3.09%
Ins Owners0.42%
Ins Owner Change1.1%
Market Cap24.41B
Analysts70.53
Price Target1281.74 (9.11%)
Short Float %3.51%
Short Ratio3.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.86%
Min EPS beat(2)2.78%
Max EPS beat(2)4.94%
EPS beat(4)4
Avg EPS beat(4)3.62%
Min EPS beat(4)1.02%
Max EPS beat(4)5.75%
EPS beat(8)6
Avg EPS beat(8)2.82%
EPS beat(12)10
Avg EPS beat(12)2.83%
EPS beat(16)14
Avg EPS beat(16)3.44%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)2.56%
Revenue beat(4)3
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)0.26%
Revenue beat(16)12
Avg Revenue beat(16)0.79%
PT rev (1m)-1.51%
PT rev (3m)-9.81%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-6.73%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-2.87%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.03 | ||
| Fwd PE | 25.32 | ||
| P/S | 6.37 | ||
| P/FCF | 28.09 | ||
| P/OCF | 25.09 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.7 |
EPS(TTM)40.46
EY3.44%
EPS(NY)46.39
Fwd EY3.95%
FCF(TTM)41.82
FCFY3.56%
OCF(TTM)46.81
OCFY3.99%
SpS184.32
BVpS-8.76
TBVpS-53.27
PEG (NY)15.67
PEG (5Y)2.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROCE | 52.99% | ||
| ROIC | 43.51% | ||
| ROICexc | 44.9% | ||
| ROICexgc | 82.8% | ||
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% | ||
| FCFM | 22.69% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 84.96% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.29% | ||
| Profit Quality | 102.34% | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 10.33 |
F-Score7
WACC9.93%
ROIC/WACC4.38
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
EPS Next Y1.85%
EPS Next 2Y6.16%
EPS Next 3Y8.2%
EPS Next 5Y9.32%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
Revenue Next Year2.19%
Revenue Next 2Y3.4%
Revenue Next 3Y3.95%
Revenue Next 5Y3.81%
EBIT growth 1Y1.9%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year5.6%
EBIT Next 3Y6.42%
EBIT Next 5Y7.26%
FCF growth 1Y9.12%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y5.56%
OCF growth 3Y2.14%
OCF growth 5Y9.92%